Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

588
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
588
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

718
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
718
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

607
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
607

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into disaster nephrology and preparedness for kidney care in emergencies.

Kidney research and clinical practice·2026
Same author

Long-term renal outcomes in living kidney donors with asymptomatic nephrolithiasis: A 10-year single-center study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Frailty assessment in kidney transplantation: insights from a European survey.

Clinical kidney journal·2026
Same author

Rising From the Storm: Applying Lessons From Disasters.

Advances in kidney disease and health·2026
Same author

Management of Antithrombotic Therapies in Kidney Transplantation Candidates and Recipients: An ERBP (European Renal Best Practice) Clinical Practice Document by the Descartes Working Group of the European Renal Association (ERA) and the Ekita Committee of the European Society of Organ Transplantation (ESOT).

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Corrigendum: Hidden in Plain Sight: High Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same journal

Successful Anesthetic Management of Deceased Donor Liver Transplant in a Patient With Neonatal Sclerosing Cholangitis As a Result of DCDC2 (doublecortin domain-containing protein 2) Mutation: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Twenty-Year Follow-up After Combined Heart and Kidney Transplant: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Fibrin Hydrogel Containing Microvascular Fragments for Improving Subcutaneous Islet Transplants in Diabetic Rats.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Investigation of the Relationship Between Antibody-Mediated Rejection and Serum Interleukin 40 Levels in Heart Transplant Patients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Effect of Body Mass Index on Complications and Survival After Living Donor Liver Transplantation.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Tacrolimus Levels 10 Years After Kidney Transplant and Long-Term Clinical Outcomes: A Propensity Score-Matched Analysis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

713

Posttransplant Tuberculosis.

Erol Demir1, Mehmet Sukru Sever

  • 1Department of Nephrology, İstanbul School of Medicine, Millet Caddesi, Çapa, İstanbul, Turkey.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|March 7, 2017
PubMed
Summary
This summary is machine-generated.

Post-transplant tuberculosis poses significant risks due to diagnostic challenges and potential graft rejection. Individualized therapy is crucial for managing tuberculosis in transplant recipients, balancing treatment efficacy with immunosuppression needs.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

Related Experiment Videos

Last Updated: Mar 6, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

713
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

Area of Science:

  • Transplant Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) is a critical concern in the post-transplant period, marked by high incidence, prevalence, diagnostic difficulties, and substantial morbidity/mortality.
  • Diagnosing TB in solid-organ transplant recipients is complex due to often subtle symptoms, potentially negative tuberculin skin tests, and insufficient sensitivity of interferon-gamma release assays.

Purpose of the Study:

  • To review the challenges in diagnosing and treating tuberculosis in transplant recipients.
  • To discuss current treatment protocols for active and latent tuberculosis in immunocompetent versus immunosuppressed individuals.
  • To highlight the drug interactions between anti-TB medications and immunosuppressants and their impact on graft survival.

Main Methods:

  • Review of existing literature on tuberculosis in transplant recipients.
  • Analysis of diagnostic challenges including imaging and laboratory tests.
  • Discussion of treatment strategies for active and latent tuberculosis.

Main Results:

  • Diagnosis of post-transplant TB is frequently delayed due to atypical presentations and unreliable diagnostic tests.
  • Treatment protocols for active TB involve intensive and continuation phases, with specific considerations for immunosuppressed patients.
  • Drug interactions between anti-TB drugs (rifamycins) and immunosuppressants increase the risk of graft rejection.

Conclusions:

  • Post-transplant tuberculosis remains a significant comorbidity, contributing to increased morbidity and mortality.
  • Individualized therapy is recommended, particularly for patients at high risk of TB.
  • Effective management requires careful consideration of diagnostic limitations and drug interactions to optimize patient outcomes and graft survival.